ESMO 2024

Oncology
Dr Meredith McKean interview with Nicole Raleigh

ESMO 2024 – Dr Meredith McKean

In our final video from ESMO 2024, web editor Nicole Raleigh spoke with Dr Meredith McKean, a melanoma investigator at the Sarah Cannon Research Institute.

Oncology
ESMO 2024 Dr Magda Meissner interview with Nicole Raleigh

ESMO 2024 – Magda Meissner

In our penultimate video from ESMO 2024, pharmaphorum spoke with Dr Magda Meissner, consultant medical oncologist at the Velindre Cancer Centre and project lead for QuicDNA, about how a sim

Oncology
Nicole Raleigh interview with Daejin Abidoye at ESMO 2024

ESMO 2024 - Daejin Abidoye

At ESMO 2024, AbbVie presented new data across their solid tumour pipeline, displaying the company’s potential as an emerging leader in solid tumours.

Oncology
Henar Hevia & Carolyn Sousa interview with Nicole Raleigh

ESMO 2024 - Henar Hevia & Carolyn Sousa

ESMO 2024 was chock full of oncological data, diverse presentations providing hope across the cancer spectrum from breast and lung to unmet needs in colorectal and bladder.

Oncology
Israel Lowy from Regeneron interview with Nicole Raleigh

ESMO 2024 - Israel (Izzy) Lowy

ESMO 2024, which followed hot on the heels of this year’s World Conference on Lung Cancer, was abuzz with data around PD-1 inhibitors, LAG-3 inhibitors, and the possibilities for using exis